Literature DB >> 6956874

Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.

M Memo, W Lovenberg, I Hanbauer.   

Abstract

Incubation, for 30 min, of striatal slices with 10 microM dopamine, 10 microM apomorphine, or 10 microM SKF 38393 decreased dopamine-stimulated adenylate cyclase activity by 50-60%. This loss in dopamine-stimulated enzyme activity appears to be mediated by a persistent occupancy of recognition sites of the D-1 receptor because: (i) at 10 microM, SKF 38393, a selective D-1 receptor agonist, facilitates desensitization and Ly 141865, a selective D-2 receptor agonist, fails to elicit desensitization of dopamine-dependent adenylate cyclase; and (ii) preincubation with dopamine in the presence of 1 microM haloperidol but not 1 microM sulpiride curtails the desensitization of dopamine-dependent adenylate cyclase. In dopamine-desensitized striatal slices of the Kd for N-propylnorapomorphine binding is increased but the content of membrane-bound calmodulin and the activation of adenylate cyclase by NaF and cholera toxin are decreased significantly. In striatal slices incubated with dopamine for prolonged time periods the coupling of the GTP-binding protein with adenylate cyclase and dopamine recognition sites may be impaired and the content of membrane-bound calmodulin is decreased.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6956874      PMCID: PMC346691          DOI: 10.1073/pnas.79.14.4456

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.

Authors:  M Gnegy; P Uzunov; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1977-09       Impact factor: 4.030

2.  Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain.

Authors:  M Trabucchi; R Longoni; P Fresia; P F Spano
Journal:  Life Sci       Date:  1975-11-15       Impact factor: 5.037

3.  Release of the phosphodiesterase activator by cyclic AMP-dependent ATP:protein phosphotransferase from subcellular fractions of rat brain.

Authors:  M E Gnegy; J A Nathanson; P Uzunov
Journal:  Biochim Biophys Acta       Date:  1977-03-29

4.  A rapid filter paper disk assay for picomole amounts of cyclic AMP using a cyclic AMP dependent protein kinase.

Authors:  F R Butcher
Journal:  Horm Metab Res       Date:  1971-09       Impact factor: 2.936

5.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

6.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

7.  Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

Authors:  D R Burt; I Creese; S H Snyder
Journal:  Science       Date:  1977-04-15       Impact factor: 47.728

8.  Regional effects of neuroleptics on dopamine metabolism and dopamine-sensitive adenylate cyclase activity.

Authors:  B Scatton; S Bischoff; J Dedek; J Korf
Journal:  Eur J Pharmacol       Date:  1977-08-15       Impact factor: 4.432

9.  Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

Authors:  Y C Clement-Cormier; J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells.

Authors:  M Shear; P A Insel; K L Melmon; P Coffino
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

View more
  9 in total

1.  G-proteins (Gi, Go) in the basal ganglia of control and schizophrenic brain.

Authors:  F Okada; T J Crow; G W Roberts
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine.

Authors:  Pamela J Voulalas; John Schetz; Ashiwel S Undieh
Journal:  Mol Cell Neurosci       Date:  2011-01-12       Impact factor: 4.314

3.  Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons.

Authors:  P A Johansen; X T Hu; F J White
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Human Pluripotent Stem Cell-Derived Medium Spiny Neuron-like Cells Exhibit Gene Desensitization.

Authors:  Ryan W Tam; Albert J Keung
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

5.  Developmental Deltamethrin Exposure Causes Persistent Changes in Dopaminergic Gene Expression, Neurochemistry, and Locomotor Activity in Zebrafish.

Authors:  Tiffany S Kung; Jason R Richardson; Keith R Cooper; Lori A White
Journal:  Toxicol Sci       Date:  2015-04-24       Impact factor: 4.849

6.  Ethanol enhances glutamate transmission by retrograde dopamine signaling in a postsynaptic neuron/synaptic bouton preparation from the ventral tegmental area.

Authors:  Chunyu Deng; Ke-Yong Li; Chunyi Zhou; Jiang-Hong Ye
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

7.  Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval.

Authors:  R Castro; P Abreu; C H Calzadilla; M Rodriguez
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.

Authors:  S W Martin; K J Broadley
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

9.  Rate of binding of various inhibitors at the dopamine transporter in vivo.

Authors:  M Stathis; U Scheffel; S Z Lever; J W Boja; F I Carroll; M J Kuhar
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.